Leukemia

Showing NaN - NaN of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, MDS Trial in Minneapolis (biological, drug, procedure, radiation)

Terminated
  • Leukemia
  • Myelodysplastic Syndromes
  • aldesleukin
  • +9 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Dec 3, 2017

Leukemia Trial in Minneapolis (biological, drug, procedure)

Completed
  • Leukemia
  • aldesleukin
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center
Dec 3, 2017

Breast Cancer, Iron Overload, Leukemia Trial in Minneapolis (deferasirox)

Terminated
  • Breast Cancer
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Dec 3, 2017

Leukemia Trial in Minneapolis (cyclosporine, cytarabine, filgrastim)

Terminated
  • Leukemia
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Dec 3, 2017

Leukemia, Lymphoma Trial in Minneapolis (cytarabine, decitabine, doxorubicin HCl)

Terminated
  • Leukemia
  • Lymphoma
  • Minneapolis, Minnesota
    University of Minnesota Amplatz Children's Hospital
Dec 3, 2017

GVHD, Leukemia, Lymphoma Trial in Minneapolis (drug, procedure, radiation)

Terminated
  • Graft Versus Host Disease
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 29, 2017

Leukemia, Lymphoma, Multiple Myeloma Trial in Minneapolis (biological, drug, radiation)

Completed
  • Leukemia
  • +4 more
  • umbilical cord blood transplantation
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 29, 2017

Leukemia, Lymphoma Trial in Minneapolis, Houston, Temple (DT2219ARL)

Completed
  • Leukemia
  • Lymphoma
  • DT2219ARL
  • Minneapolis, Minnesota
  • +2 more
Nov 29, 2017

Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin,

Terminated
  • Chronic Myeloproliferative Disorders
  • +8 more
  • anti-thymocyte globulin
  • +9 more
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Nov 27, 2017

Leukemia Trial in Minneapolis (cyclophosphamide, filgrastim, recombinant interferon alfa)

Terminated
  • Leukemia
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Nov 27, 2017

Leukemia Trial in Minneapolis (yttrium Y 90 anti-CD19 mAb BU12, 111In-BU-12)

Terminated
  • Leukemia
  • yttrium Y 90 anti-CD19 monoclonal antibody BU12
  • 111In-BU-12
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 27, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • filgrastim
  • +7 more
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Nov 27, 2017

Leukemia, MDS Trial in Minneapolis (anti-CD45 mAb AHN-12, yttrium Y 90 anti-CD45 mAb AHN-12)

Terminated
  • Leukemia
  • Myelodysplastic Syndromes
  • anti-CD45 monoclonal antibody AHN-12
  • yttrium Y 90 anti-CD45 monoclonal antibody AHN-12
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 27, 2017

Germ Cell Tumor, Leukemia, Lymphoma Trial in Minneapolis (keyhole limpet hemocyanin, tetanus toxoid)

Terminated
  • Germ Cell Tumor
  • +3 more
  • keyhole limpet hemocyanin
  • tetanus toxoid
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 27, 2017

GVHD, Leukemia, Lymphoma Trial in Minneapolis (CD4+CD25+ regulatory T cells, allogeneic hematopoietic stem cell transplantation)

Terminated
  • Graft Versus Host Disease
  • +4 more
  • CD4+CD25+ regulatory T cells
  • allogeneic hematopoietic stem cell transplantation
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 27, 2017

Leukemia Trial in Minneapolis (busulfan, cyclophosphamide, filgrastim)

Terminated
  • Leukemia
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Nov 27, 2017

Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

Completed
  • Leukemia
  • +2 more
  • Allogeneic bone marrow transplantation
  • Peripheral blood stem cell transplantation
  • Birmingham, Alabama
  • +44 more
Oct 24, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

Completed
  • Chronic Myeloproliferative Disorders
  • +9 more
  • baclofen/amitriptyline/ketamine gel
  • placebo
  • Scottsdale, Arizona
  • +164 more
Jul 25, 2017

Leukemia Trial in Canada, United States (clofarabine, cytarabine, methotrexate)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +78 more
May 3, 2017

GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 30, 2017

Leukemia Trial in Worldwide (biological, drug, radiation)

Completed
  • Leukemia
  • filgrastim
  • +12 more
  • Birmingham, Alabama
  • +152 more
Feb 14, 2017

Leukemia Trial in United States (cytarabine, idarubicin, lestaurtinib)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +20 more
Feb 7, 2017

Leukemia, Lymphoma, MDS Trial in Minneapolis, Madison (calcium, cholecalciferol, zoledronic acid)

Completed
  • Leukemia
  • +4 more
  • calcium
  • +2 more
  • Minneapolis, Minnesota
  • +1 more
Jan 26, 2017

Leukemia Trial in Australia, Canada, United States (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Leukemia
  • Long Beach, California
  • +33 more
Feb 7, 2017

Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

Completed
  • Chronic Myeloproliferative Disorders
  • +9 more
  • American ginseng
  • placebo
  • Scottsdale, Arizona
  • +325 more
Dec 19, 2016